FDA issued a Warning Letter to Nexgen Pharma Inc on 9/27/2010 for a previous inspection.
483 Nexgen Pharma Oct 2017

483 Nexgen Pharma Oct 2017

Vioela Caze FDA, Bryan Galvez FDA, Truong Nguyen FDA, Christopher Washington FDA$119.00 - Available Now

FDA investigators audited the Nexgen Pharma - Irvine, CA, United States facility and issued inspectional observations (via FDA 483) on 20 Oct 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Oct 2017
  • Location: Irvine, United States
  • FEI: 2011194
Add To Cart